Amber Bio co-founders Jacob Borrajo (L) and Basem Al-Shayeb

Play­ground Glob­al, a16z back $26M seed for RNA edit­ing start­up aim­ing to ad­dress mul­ti­ple mu­ta­tions with sin­gle shot

The ad­vent of CRISPR tech­nolo­gies for gene edit­ing has opened up the pos­si­bil­i­ty of treat­ing ge­net­ic dis­or­ders by mak­ing pre­cise changes to pa­tients’ DNA or …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.